Furthermore, the detailed information regarding CD31 and β-catenin downregulation targets should be studied in the exosomal cargo to decipher breast cancer cells’ novel regulatory mechanisms and invasiveness. The gene discussed is PECAM1; the disease is breast carcinoma.